Amedica has been granted marketing clearance in Australia for Valeo® silicon nitride ceramic interbody fusion devices.
Leadership notes that, in 1986-1988, Australian surgeons and engineers were the first to synthesize reaction-bonded silicon nitride and implant the material in lumbar spine fusion patients. Favorable outcomes were reported at 15-year follow-up.
In the U.S., at the end of 2016, the company re-filed an application with FDA for a modified cancellous-structured ceramic (CsC)-based cervical implant that is comparable to the Valeo C cervical implant.
Amedica has been granted marketing clearance in Australia for Valeo® silicon nitride ceramic interbody fusion devices.
Leadership notes that, in 1986-1988, Australian surgeons and engineers were the first to synthesize reaction-bonded silicon nitride and implant the material in lumbar spine fusion patients. Favorable outcomes were reported...
Amedica has been granted marketing clearance in Australia for Valeo® silicon nitride ceramic interbody fusion devices.
Leadership notes that, in 1986-1988, Australian surgeons and engineers were the first to synthesize reaction-bonded silicon nitride and implant the material in lumbar spine fusion patients. Favorable outcomes were reported at 15-year follow-up.
In the U.S., at the end of 2016, the company re-filed an application with FDA for a modified cancellous-structured ceramic (CsC)-based cervical implant that is comparable to the Valeo C cervical implant.
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more
Copy to clipboard 
